Pharmahungary Group: Clinical Trials

3 trials sponsored by Pharmahungary Group, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 1 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 41Completed 1

Follow Pharmahungary Group: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Performance Evaluation of the DualDur In Vitro Diagnostic System in the Diagnosis of Lyme Borreliosis
DualDur dark-field microscopic test, DualDur dark-field automatic microscopic test, Western blot IgM and IgG - Lyme Borreliosis
CompletedLyme Diagnostics Ltd.4002019-07-022020-03-02
Budapest Upgrade CRT Study (Version 009-4.1)
CRT-D - Cardiomyopathy
Not applicableCompletedSemmelweis University Heart and Vascular Center3602014-11-012023-06-06
Observational Study on the Pharmacokinetics of Oseltamivir in the Treatment of Influenza During Lactation
Oseltamivir - Influenza
Phase 4CompletedPharmahungary Group62010-06-012012-10-08

Conditions studied

Cardiomyopathies (1)  ·  Influenza, Human (1)  ·  Lyme Disease (1)

Interventions

Hardness (1)  ·  Oseltamivir (1)

Countries

Hungary (3)  ·  Germany (2)  ·  Poland (2)  ·  Slovakia (2)  ·  Austria (1)  ·  Czechia (1)  ·  Israel (1)  ·  Serbia (1)  ·  Slovenia (1)

Top investigators

Annamaria Kosztin, MD (1)  ·  Bela P. Bozsik, MD (1)  ·  Ilan Goldenberg, Prof. MD (1)  ·  Valentina Kutyifa, MD (1)

Results publications

PMID 28339581, PMID 35791276, PMID 39614838